SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company
Related news for (SOPH)
- SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
- SOPHiA GENETICS Supports Genetic Testing in Brazil
- SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
- SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
- SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results